The last few years have transformed the pharma industry, be it the disruptive innovation in R&D, the Vaccine revolution, newer therapies, or the new commercial models.

In a recent article by Alvarez and Marsal, the author commented there is a need to further reshape and keep evolving the customer-facing commercial models in pharma.